City of Hope

www.cityofhope.org

 

Insights from 2025 ASCO® GU Annual Meeting
A

ASCO® GU 2025 Insights: TRITON3 Final OS and Safety - Rucaparib vs. Docetaxel or Second-Generation ARPI in mCRPC

By Insights from 2025 ASCO® GU Annual Meeting FEATURING Alan Bryce
By Insights from 2025 ASCO® GU Annual Meeting FEATURING Alan Bryce
5 views
April 11, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy
Genitourinary
04:08

New

ASCO® GU 2025 Insights: TRITON3 Final OS and Safety - Rucaparib vs. …

Insights from 2025 ASCO® GU Annual Meeting

A. Bryce

05:46

ASCO® GU 2024 Summary: "Adherence to ASCO® Language of Respect Guide…

Insights from 2024 ASCO® GU Annual Meeting

R. Barragán Carrillo

57 views
16:51

A Practical Guide to Relugolix: Early Experience With Oral Androgen …

City of Hope

S. Kasparian

482 views
45:34

Evolving Treatment Concepts and New Data in Advanced Prostate Cancer

i3 Health

T. Barauskas Dorff

254 views
16:16

Equity in Access to GU Clinical Trials: What Are the Factors That Ma…

Virtual Diversity in Cancer Care

T. Barauskas Dorff

15 views